Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV plus R/M HNSCC)-MedSci.cn

Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV plus R/M HNSCC)

Aggarwal, C; Saba, NF; Algazi, AP; Sukari, A; Seiwert, T; Haigentz, M; Porosnicu, M; Bonomi, M; Boyer, J; Durham, N; Kumar, R; Laubscher, K; Gong, M; Ceaicovscaia, N; Hernandez, AG

ANNALS OF ONCOLOGY, 2020; 31 (): S661

科室
- - 订阅+
  - 更多科室
工具
服务